Skip to main content
SpringerLink
Log in

Neuroprotection in Spinal Cord Injury

  • Protocol
  • First Online:
The Handbook of Neuroprotection

Part of the book series: Springer Protocols Handbooks ((SPH))

  • 806 Accesses

Abstract

Spinal cord injury (SCI) can lead to serious neurological disability and the most serious form of it is paraplegia or quadriplegia. The effects of SCI are extensive and adversely affect multiple organ systems including the sensorimotor, respiratory, gastrointestinal, urinary and reproductive systems. The psycho-social effects are devastating, and the financial burden associated with SCI is staggering. As a result of advances in critical care and rehabilitation, the life span of these patients has been extended to as much as 40 years post-injury. However, there is no therapeutic measure available currently that enhances functional recovery significantly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abematsu M, Tsujimura K, Yamano M, et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest 2010;120:3255–66.

    Article  CAS  Google Scholar 

  • Bilginer B, Onal MB, Narin F, et al. Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats. Childs Nerv Syst 2009;25:1555–61.

    Article  Google Scholar 

  • Bradbury EJ, Carter LM. Manipulating the glial scar: Chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2011;84:306–16.

    Article  CAS  Google Scholar 

  • Buss A, Pech K, Kakulas BA, et al. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury. BMC Neurology 2007;7:17.

    Article  Google Scholar 

  • Casha S, Zygun D, McGowan MD, et al. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 2012;135(Pt 4):1224–36.

    Article  Google Scholar 

  • Chen G, Fang X, Yu M. Regulation of gene expression in rats with spinal cord injury based on microarray data. Mol Med Rep 2015;12:2465–72.

    Article  CAS  Google Scholar 

  • Deda H, Inci M, Kurekci A, et al. Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy 2008;10:565–74.

    Article  CAS  Google Scholar 

  • Gensel JC, Wang Y, Guan Z, et al. Toll-like receptors and dectin-1, a C-type lectin receptor, trigger divergent functions in CNS macrophages. J Neurosci 2015;35:9966–76.

    Article  CAS  Google Scholar 

  • Hurlbert RJ, Hadley MN, Walters BC, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery 2015;76 Suppl 1:S71–83.

    Article  Google Scholar 

  • Jain KK. Hyperbaric oxygen therapy in neurosurgery. In, Jain KK. Textbook of Hyperbaric Medicine, 6th ed. Springer, New York 2017.

    Chapter  Google Scholar 

  • Kalayci M, Coskun O, Cagavi F, et al. Neuroprotective effects of ebselen on experimental spinal cord injury in rats. Neurochem Res 2005;30:403–10.

    Article  CAS  Google Scholar 

  • Li N, Leung GK. Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update. Biomed Res Int 2015;2015:235195.

    PubMed  PubMed Central  Google Scholar 

  • Ma YH, Zhang Y, Cao L, et al. Effect of neurotrophin-3 genetically modified olfactory ensheathing cells transplantation on spinal cord injury. Cell Transplant 2010;19:167–77.

    Article  Google Scholar 

  • Mackay-Sim A, Féron F, Cochrane J, et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 2008;131:2376–86.

    Article  CAS  Google Scholar 

  • McKerracher L, Anderson KD. Analysis of recruitment and outcomes in the phase I/IIa Cethrin clinical trial for acute spinal cord injury. J Neurotrauma 2013;30:1795–804.

    Article  Google Scholar 

  • Meletis K, Barnabé-Heider F, Carlén M, et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol 2008;6(7):e182.

    Article  Google Scholar 

  • Monaco EA 3rd, Weiner GM, Friedlander RM. Randomized-controlled trial of minocycline for spinal cord injury shows promise. Neurosurgery 2013;72:N17–9.

    Article  Google Scholar 

  • Morino T, Ogata T, Takeba J, Yamamoto H. Microglia inhibition is a target of mild hypothermic treatment after the spinal cord injury. Spinal Cord 2008;46:425–31.

    Article  CAS  Google Scholar 

  • Mountney A, Zahner MR, Lorenzini I, et al. Sialidase enhances recovery from spinal cord contusion injury. PNAS 2010;107:11561–6.

    Article  CAS  Google Scholar 

  • Naghdi M, Tiraihi T, Namin SA, et al. Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: a potential source for cell therapy in spinal cord injury. Cytotherapy 2009;11:137–52.

    Article  CAS  Google Scholar 

  • Nishimura S, Sasaki T, Shimizu A, et al. Global gene expression analysis following spinal cord injury in non-human primates. Exp Neurol 2014;261:171–9.

    Article  CAS  Google Scholar 

  • Nori S, Ahuja CS, Fehlings MG. Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot? Neurosurgery 2017;64(CN suppl 1):119–128.

    Article  Google Scholar 

  • Oh SK, Choi KH, Yoo JY, et al. A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 2016;78:436–47.

    Article  Google Scholar 

  • Park JH, Kim DY, Sung IY, et al. Long-term Results of Spinal Cord Injury Therapy Using Mesenchymal Stem Cells Derived From Bone Marrow in Humans. Neurosurgery 2012;70:1238–47.

    Article  Google Scholar 

  • Ronsyn MW, Daans J, Spaepen G, et al. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnology 2007;7:90.

    Article  Google Scholar 

  • Sakai K, Yamamoto A, Matsubara K, et al. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest 2012;122:80–90.

    CAS  PubMed  Google Scholar 

  • Sharp J, Frame J, Siegenthaler M, et al. Human embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury. Stem Cells 2010;28:152–63.

    Google Scholar 

  • Snyder EY, Teng YD. Stem Cells and Spinal Cord Repair. N Engl J Med 2012;366:1940–42.

    Article  CAS  Google Scholar 

  • Tabakow P, Jarmundowicz W, Czapiga B, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant 2013;22:1591–612.

    Article  Google Scholar 

  • Tator CH, Hashimoto R, Raich A, et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J Neurosurg Spine 2012;17(1 Suppl):157–229.

    Article  Google Scholar 

  • Tong J, Ren Y, Wang X, et al. Assessment of Nogo-66 receptor 1 function in vivo after spinal cord injury. Neurosurgery 2014;75:51–60.

    Article  Google Scholar 

  • Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 2010;107:12704–9.

    Article  CAS  Google Scholar 

  • Wu JC, Huang WC, Tsai YA, et al. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study. J Neurosurg Spine 2008;8:208–214.

    Article  Google Scholar 

  • Yan J, Xu L, Welsh AM, et al. Extensive Neuronal Differentiation of Human Neural Stem Cell Grafts in Adult Rat Spinal Cord. PLoS Med 2007;4:e39.

    Article  Google Scholar 

  • Yeo JE, Kim JH, Kang SK. Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study. Cell Physiol Biochem 2008;21(1–3):225–38.

    Article  CAS  Google Scholar 

  • Zhang J, Zhang A, Sun Y, et al. Treatment with immunosuppressants FTY720 and tacrolimus promotes functional recovery after spinal cord injury in rats. Tohoku J Exp Med 2009;219:295–302.

    Article  CAS  Google Scholar 

  • Zhou Z, Peng X, Insolera R, et al. IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol 2009;220:183–90.

    Article  CAS  Google Scholar 

  • Zhou Y, Wang Z, Li J, et al. Fibroblast growth factors in the management of spinal cord injury. J Cell Mol Med 2018;22:25–37.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jain PharmaBiotech, Basel, Switzerland

    Kewal K. Jain

Authors
  1. Kewal K. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jain, K.K. (2019). Neuroprotection in Spinal Cord Injury. In: The Handbook of Neuroprotection. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9465-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9465-6_5

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9464-9

  • Online ISBN: 978-1-4939-9465-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation